Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Avacopan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InflaRx: Favorable Izicopan Metabolite Profile in Humans
    InflaRx: Favorable Izicopan Metabolite Profile in Humans

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286600/0/en/inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Amgen Updates Tavneos Label Amid FDA Withdrawal Push
    Amgen Updates Tavneos Label Amid FDA Withdrawal Push

    01 May 2026

    // ENDPOINTS

    https://endpoints.news/amgen-files-update-to-tavneos-label-as-fda-escalates-push-to-withdraw/

    ENDPOINTS
    01 May 2026
    Share Share
    FDA Proposes to withdraw Amgen's drug for Rare Autoimmune Disease
    FDA Proposes to withdraw Amgen's drug for Rare Autoimmune Disease

    27 Apr 2026

    // REUTERS

    https://www.reuters.com/legal/litigation/fda-proposes-withdraw-amgens-rare-autoimmune-disease-drug-2026-04-28/

    REUTERS
    27 Apr 2026
    Share Share
    FDA warns of liver injury cases tied to Amgen's Rare Disease Drug
    FDA warns of liver injury cases tied to Amgen's Rare Disease Drug

    31 Mar 2026

    // FDA

    https://www.fda.gov/media/191708/download?attachment

    FDA
    31 Mar 2026
    Share Share
    Amgen Thumbs-Down on FDA’s ask, Tavneos Sales Continue
    Amgen Thumbs-Down on FDA’s ask, Tavneos Sales Continue

    05 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgen-resists-fda-request-pull-rare-disease-drug-tavneos-market-0

    FIERCE PHARMA
    05 Feb 2026
    Share Share
    Amgen's ChemoCentryx Wins Investor Lawsuit
    Amgen's ChemoCentryx Wins Investor Lawsuit

    19 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgens-chemocentryx-prevails-investor-lawsuit-around-autoimmune-drug-tavneos

    FIERCE PHARMA
    19 Aug 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.